Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a **sterile intravenous crystalloid and carbohydrate replacement solution** containing **sodium chloride, sodium lactate, potassium chloride, calcium chloride, and dextrose monohydrate**. Marketed as **Lactated Ringer's and Dextrose (5%) Injection**, it is used as a source of **water, electrolytes, and calories** and as an **alkalinizing agent** in adults and pediatric patients. Its pharmacologic effect is not mediated through a single discrete receptor; rather, it restores extracellular fluid volume and electrolyte composition, while the **lactate** component is metabolized to bicarbonate precursors that help buffer metabolic acidosis and the **dextrose** provides minimal caloric support. Public labeling and product information identify ICU Medical as a current commercial source, with historical Hospira labeling also associated with the product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium chloride + sodium lactate + potassium chloride + dextrose monohydrate + sodium chloride.